SpeedySwab™ Rapid COVID-19 + Flu A&B Antigen Self-Test (OTC Version)

Fast, Reliable At-Home Testing for COVID-19 & Flu

The SpeedySwab™ Rapid COVID-19 + Flu A&B Antigen Self-Test is a simple and convenient at-home test designed to quickly and accurately differentiate between COVID-19 and influenza A & B. This test provides rapid results in just 15 minutes, helping individuals make informed health decisions.

Key Features:

• Dual Detection: Differentiates between COVID-19, Flu A, and Flu B with a single test.

• Fast & Reliable: Results in just 15 minutes for quick action.

• Easy-to-Use: Simple anterior nasal swab collection, with self-collection for ages 14+ and adult-assisted collection for ages 2+.

• At-Home Convenience: No prescription or lab visit required.

• Up to 18-Month Shelf Life: Ensures availability when needed.
  
  

Who Can Use It?

Individuals with symptoms of respiratory infection consistent with COVID-19 or the flu.

• Ages 14+ can self-collect their sample.

• Ages 2+ require an adult to collect the sample.

This test is authorized for non-prescription home use and should be performed twice over three days, at least 48 hours apart, for the most accurate results. 

Where to Buy

1.

Patients consult with their healthcare provider to assess if LEAP is appropriate for them. 

2.

A LEAP blood sample is collected at the healthcare provider’s office or via as Ease Healthcare partner. 

3.

The ordering physician receives results within within a few days of sample receipt at the lab. 

More Information About the SpeedySwab™ Test

• How does the SpeedySwab™ Rapid COVID-19 + Flu A&B Test work?

  SpeedySwab™ is a lateral flow antigen test that detects and differentiates COVID-19, Influenza A, and Influenza B proteins using a simple nasal swab sample. The test provides results in just 15 minutes.

• Who can use this test?

  This test is authorized for:

  • Individuals aged 14+ who can self-collect their nasal swab.

  • Children ages 2-13, with an adult collecting the sample.

  • Individuals experiencing symptoms of respiratory infection consistent with COVID-19 or the flu, within the first five (5) days of symptom onset.

  Physicians may also consider individuals with a family history of lung cancer or elevated risk due to environmental exposure and other risk-factors. LEAP can serve as a decision aid for individuals putting off lung cancer screening due to concerns about radiation exposure and the need for repeat scans over time.

  The referring physician should judge a patient’s risk in light of clinical factors following conversations with the patient. LEAP is not for those already diagnosed with lung cancer or currently undergoing treatment for lung cancer.

• How accurate is the test?

  The test has been clinically validated with the following sensitivity rates:

  • COVID-19: 92.6%

  • Flu A: 82.9%

  • Flu B: 90%

• How do I interpret the test results?

  The test device includes three separate result lines:

  • COVID-19 (SARS-CoV-2) Line

  • Influenza A Line

  • Influenza B Line
    A control line ensures that the test was performed correctly. Instructions on result interpretation are included in the test kit.

• How often should I test?

  For the most accurate results, it is recommended to test at least twice over three days, with at least 48 hours between tests.

• Is the SpeedySwab™ test FDA authorized?

  Yes, the test has received Emergency Use Authorization (EUA #EUA240014) from the U.S. FDA.

---

Additional Product Information & Resources